Lenalidomide in solid tumors

Cancer Chemotherapy and Pharmacology
Angela Segler, Apostolia-Maria Tsimberidou

Abstract

Lenalidomide is a thalidomide analogue with immunomodulatory and anti-angiogenic properties that include altering cytokine production, activating T cells, and augmenting natural killer cell function. Lenalidomide is approved by the U.S. Food and Drug Administration (FDA) for single-agent treatment of myelodysplastic syndromes associated with a 5q deletion and as a combination therapy with dexamethasone for the treatment of multiple myeloma. All prospective phase I-III clinical trials and preclinical data published until October 2011 and relevant literature were reviewed. In phase I and/or II studies of single-agent lenalidomide in patients with advanced cancer, responses were reported in patients with prostate, thyroid, hepatocellular, pancreatic, and renal cancer and melanoma. The most common toxicities were hematologic, and in the first clinical trials, thrombotic events were noted. When anticoagulation prophylaxis and exclusion of patients with a history of thrombosis were implemented, thrombotic complications became uncommon. Monitoring of blood counts and for evidence of thromboembolic events is essential for patients treated with lenalidomide. Ongoing trials of lenalidomide combination therapy offer a treatment option for...Continue Reading

References

Jun 1, 1993·The Journal of Experimental Medicine·A L MoreiraG Kaplan
Jul 1, 1999·Bioorganic & Medicinal Chemistry Letters·G W MullerD I Stirling
Dec 12, 2001·Seminars in Oncology·D Stirling
Mar 21, 2002·Nature Reviews. Cancer·Adrian L Harris
Mar 27, 2002·Endocrine-related Cancer·K W Colston, C Mørk Hansen
May 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keith DredgeAngus G Dalgleish
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Noriyuki KataokaFumihiko Kajiya
Sep 27, 2003·Blood·Richard LeBlancNikhil C Munshi
Jan 30, 2004·Cancer Cell·Mikhail V Blagosklonny
Oct 27, 2004·Apoptosis : an International Journal on Programmed Cell Death·M OsakiH Ito
Nov 4, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Tanyifor M TohnyaWilliam D Figg
Aug 9, 2005·Seminars in Oncology·Robert Knight
May 26, 2006·Nature·Jacques PouysségurNathalie M Mazure
Aug 11, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A SharmaA G Dalgleish
Aug 16, 2006·The New England Journal of Medicine·Arlene H Sharpe, Abul K Abbas
Nov 1, 2006·Cancer·Toni K ChoueiriRonald M Bukowski
Mar 21, 2007·The International Journal of Biochemistry & Cell Biology·Magda Melchert, Alan List
May 3, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Antonius A MillerSusan A Melin
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Howard A FineCheryl Royce
Dec 28, 2007·Investigational New Drugs·Premal H PatelRobert J Motzer
Jun 3, 2008·International Journal of Radiation Oncology, Biology, Physics·Jan DrappatzPatrick Y Wen
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lei WuJ Blake Bartlett
Nov 18, 2008·Investigational New Drugs·Sharon L SanbornMatthew M Cooney
May 20, 2009·Journal of Clinical Pharmacology·William L DahutWilliam D Figg
Aug 14, 2009·Journal of Hematology & Oncology·Venumadhav KotlaAmit Verma
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian I RiniRobert Dreicer
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yang-Min NingWilliam L Dahut

❮ Previous
Next ❯

Citations

Aug 29, 2013·Investigational New Drugs·Prasanth GanesanApostolia M Tsimberidou
Jun 20, 2014·World Journal of Gastroenterology : WJG·Maria Caterina PallottiMaria Abbondanza Pantaleo
Sep 12, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F SelleE Pujade-Lauraine
Apr 30, 2014·European Journal of Immunology·Massimo VitaleLorenzo Moretta
Jun 13, 2013·Investigational New Drugs·Prasanth GanesanApostolia M Tsimberidou
Apr 18, 2016·Cancer Chemotherapy and Pharmacology·Rabih SaidApostolia M Tsimberidou
Jan 7, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antoine HollebecqueValérie Boige
Jun 19, 2013·Journal of Neuroscience Methods·Amelia A SchendelJustin C Williams
Feb 20, 2015·Hematology·Catherine M Bollard, A John Barrett
Jul 15, 2015·Archives of Endocrinology and Metabolism·Patrizia MondelloSalvatore Benvenga
Apr 27, 2018·International Journal of Endocrinology and Metabolism·Arash OrdookhaniKenneth D Burman
Oct 14, 2018·Cancer Research·Yuki FujiwaraYuwen Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.